Search for: [Abstract = "=1,00\). The results of women treated with fluoxetine were significantly lower \(p<0,05\) in the 2nd and 3rd measurement after treatment when compared to the results of the placebo group measured at the same periods of time The results obtained in the subgroup of symptoms A of the Green’s Climacteric Scale became significantly lower as the study progressed \(p<0,001\), and the drop was significantly faster in the group taking fluoxetine than placebo \(p<0,001\) . The group of women treated with fluoxetine already in the first measurement after the drug was introduced displayed a significant \(p<0,001\) drop of results in the said scale. On the other hand, in case of women taking placebo a significant \(p<0,05\) drop of result took place only after the second measurement. The objective of the study was to evaluate the effectiveness of fluoxetine for treatment of vasomotor symptoms and weight reduction. In the present study we focused on healthy women, who suffer from obesity. The aetiology of vasomotor symptoms \(hot flashes and night sweating\) is not clear. H. H. G. Berendsen’s hypothesis established the role of serotonin in initiating hot flash events. Berendsen suggested the potential role of SSRI in diminishing the severity of vasomotor symptoms. Available studies on the SSRI referred mostly to women with breast cancer history or in high risk group. The meta\-analysis from 2006 ev"]

Number of results: 1